tooluniverse-gwas-study-explorer（Tooluniverse GWAS 研究浏览器）

GWAS Study Deep Dive & Meta-Analysis

Compare GWAS studies, perform meta-analyses, and assess replication across cohorts

Overview

The GWAS Study Deep Dive & Meta-Analysis skill enables comprehensive comparison of genome-wide association studies (GWAS) for the same trait, meta-analysis of genetic loci across studies, and systematic assessment of replication and study quality. It integrates data from the NHGRI-EBI GWAS Catalog and Open Targets Genetics to provide a complete picture of the genetic architecture of complex traits.

Key Capabilities

1. Study Comparison: Compare all GWAS studies for a trait, assessing sample sizes, ancestries, and platforms
2. Meta-Analysis: Aggregate effect sizes across studies and calculate heterogeneity statistics
3. Replication Assessment: Identify replicated vs novel findings across discovery and replication cohorts
4. Quality Evaluation: Assess statistical power, ancestry diversity, and data availability

COMPUTE, DON'T DESCRIBE

When analysis requires computation (statistics, data processing, scoring, enrichment), write and run Python code via Bash. Don't describe what you would do — execute it and report actual results. Use ToolUniverse tools to retrieve data, then Python (pandas, scipy, statsmodels, matplotlib) to analyze it.

Domain Reasoning: Comparing Studies for the Same Trait

When comparing GWAS studies for the same trait, ask: do they replicate? The same lead SNPs appearing in independent studies is strong evidence of a true association. Different lead SNPs at the same locus may reflect LD differences between populations — they may tag the same causal variant. Different loci entirely may reflect different study designs, phenotype definitions, or population ancestry. Before concluding that a finding failed to replicate, check whether the SNP was even genotyped or imputed in the replication cohort.

LOOK UP DON'T GUESS: effect sizes, p-values, allele frequencies, and LD structure for specific loci. Do not assume a SNP present in one study is present in another — use gwas_get_associations_for_snp to retrieve cross-study data. Do not infer LD blocks from genomic proximity; use credible sets from Open Targets for fine-mapping results.

Use Cases

1. Comprehensive Trait Analysis

Scenario: "I want to understand all available GWAS data for type 2 diabetes"

Workflow:

• Search for all T2D studies in GWAS Catalog
• Filter by sample size and ancestry
• Extract top associations from each study
• Identify consistently replicated loci
• Assess ancestry-specific effects

Outcome: Complete landscape of T2D genetics with replicated findings and population-specific signals

2. Locus-Specific Meta-Analysis

Scenario: "Is the TCF7L2 association with T2D consistent across all studies?"

Workflow:

• Retrieve all TCF7L2 (rs7903146) associations for T2D
• Calculate combined effect size and p-value
• Assess heterogeneity (I² statistic)
• Generate forest plot data
• Interpret heterogeneity level

Outcome: Quantitative assessment of effect size consistency with heterogeneity interpretation

3. Replication Analysis

Scenario: "Which findings from the discovery cohort replicated in the independent sample?"

Workflow:

• Get top hits from discovery study
• Check for presence and significance in replication study
• Assess direction consistency
• Calculate replication rate
• Identify novel vs failed replication

Outcome: Systematic replication report with success rates and failed findings

4. Multi-Ancestry Comparison

Scenario: "Are T2D loci consistent across European and East Asian populations?"

Workflow:

• Filter studies by ancestry
• Compare top associations between populations
• Identify shared vs population-specific loci
• Assess allele frequency differences
• Evaluate transferability of genetic risk scores

Outcome: Ancestry-specific genetic architecture with transferability assessment

Statistical Methods

Meta-Analysis Approach

This skill implements standard GWAS meta-analysis methods:

Fixed-Effects Model:

• Used when heterogeneity is low (I² < 25%)
• Weights studies by inverse variance
• Assumes true effect size is the same across studies

Random-Effects Model (recommended when I² > 50%):

• Accounts for between-study variation
• More conservative than fixed-effects
• Better for diverse ancestries or methodologies

Heterogeneity Assessment:

The I² statistic measures the percentage of variance due to between-study heterogeneity:

I² = [(Q - df) / Q] × 100%

where Q = Cochran's Q statistic
      df = degrees of freedom (n_studies - 1)

Interpretation Guidelines:

• I² < 25%: Low heterogeneity → fixed-effects appropriate
• I² = 25-50%: Moderate heterogeneity → investigate sources
• I² = 50-75%: Substantial heterogeneity → random-effects preferred
• I² > 75%: Considerable heterogeneity → meta-analysis may not be appropriate

Sources of Heterogeneity

Common reasons for high I²:

1. Ancestry differences: Different allele frequencies and LD structure
2. Phenotype heterogeneity: Trait definition varies across studies
3. Platform differences: Imputation quality and coverage
4. Winner's curse: Discovery studies overestimate effect sizes
5. Cohort characteristics: Age, sex, environmental factors

Recommendations:

• Perform subgroup analysis by ancestry
• Use meta-regression to investigate sources
• Consider excluding outlier studies
• Apply genomic control correction

Study Quality Assessment

Quality Metrics

The skill evaluates studies based on:

1. Sample Size:

• Power to detect associations (80% power requires n > 10,000 for OR=1.2)
• Precision of effect size estimates
• Ability to detect modest effects

2. Ancestry Diversity:

• Single-ancestry vs multi-ancestry
• Population stratification control
• Transferability of findings

3. Data Availability:

• Summary statistics available for meta-analysis
• Individual-level data vs summary-level
• Imputation quality scores

4. Genotyping Quality:

• Platform density and coverage
• Imputation reference panel
• Quality control measures

5. Statistical Rigor:

• Genome-wide significance threshold (p < 5×10⁻⁸)
• Multiple testing correction
• Replication in independent cohort

Quality Tiers

Tier 1 (High Quality):

• n ≥ 50,000
• Summary statistics available
• Multi-ancestry or large single-ancestry
• Imputed to high-quality reference
• Independent replication

Tier 2 (Moderate Quality):

• n ≥ 10,000
• Standard GWAS platform
• Adequate power for common variants
• Some data availability

Tier 3 (Limited):

• n < 10,000
• Limited power
• May miss modest effects
• Use with caution

Best Practices

Before Meta-Analysis

1. Check phenotype consistency: Ensure studies measure the same trait
2. Verify ancestry overlap: High heterogeneity expected if ancestries differ
3. Harmonize alleles: Align effect alleles across studies
4. Quality control: Exclude low-quality studies or associations

Interpreting Results

1. Genome-wide significance: p < 5×10⁻⁸ (Bonferroni for ~1M independent tests)
2. Replication threshold: p < 0.05 in independent cohort
3. Direction consistency: Effect should be same direction across studies
4. Heterogeneity: I² > 50% suggests caution in interpretation

Common Pitfalls

❌ Don't:

• Meta-analyze without checking heterogeneity
• Ignore ancestry differences
• Over-interpret nominal p-values
• Assume replication failure means false positive

✅ Do:

• Always report I² statistic
• Perform sensitivity analyses
• Consider ancestry-stratified analysis
• Account for winner's curse in discovery studies

Limitations & Caveats

Data Limitations

1. Incomplete Overlap: Studies may analyze different SNPs
2. Cohort Overlap: Some cohorts participate in multiple studies (inflates significance)
3. Publication Bias: Significant findings more likely to be published
4. Winner's Curse: Discovery studies overestimate effect sizes
5. Imputation Quality: Varies across studies and populations

Statistical Limitations

1. Heterogeneity: High I² may preclude meaningful meta-analysis
2. Sample Size Differences: Large studies dominate fixed-effects models
3. Allele Frequency Differences: Same variant has different effects across ancestries
4. Linkage Disequilibrium: Fine-mapping needed to identify causal variants
5. Gene-Environment Interactions: Not captured in standard meta-analysis

Interpretation Guidelines

When I² > 75%:

• Meta-analysis results should be interpreted with extreme caution
• Investigate sources of heterogeneity systematically
• Consider ancestry-specific or subgroup analyses
• Descriptive comparison may be more appropriate than meta-analysis

When Studies Conflict:

• Check for methodological differences
• Verify phenotype definitions match
• Investigate population stratification
• Consider conditional analysis

Tools Used

GWAS Catalog API

• gwas_search_studies: Find studies by trait
• gwas_get_study_by_id: Get detailed study metadata
• gwas_get_associations_for_study: Retrieve study associations
• gwas_get_associations_for_snp: Get SNP associations across studies
• gwas_search_associations: Search associations by trait

Open Targets Genetics GraphQL API

• OpenTargets_search_gwas_studies_by_disease: Disease-based study search
• OpenTargets_get_gwas_study: Detailed study information with LD populations
• OpenTargets_get_variant_credible_sets: Fine-mapped loci for variant
• OpenTargets_get_study_credible_sets: All credible sets for study
• OpenTargets_get_variant_info: Variant annotation and allele frequencies

Glossary

Credible Set: Set of variants likely to contain the causal variant (from fine-mapping)

L2G (Locus-to-Gene): Score predicting which gene is affected by a GWAS locus License: Open source (MIT)